L-DOPA treatment duration versus Parkinson's Disease progression: The dorsal-ventral divide
Identifieur interne : 000945 ( Main/Exploration ); précédent : 000944; suivant : 000946L-DOPA treatment duration versus Parkinson's Disease progression: The dorsal-ventral divide
Auteurs : Pauline Belujon ; Anthony A. GraceSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2013.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Dopamine Agents.
- drug therapy : Parkinson Disease.
- physiopathology : Basal Ganglia, Parkinson Disease.
- Female, Humans, Male.
Url:
DOI: 10.1002/mds.25334
PubMed: 23401218
PubMed Central: 4460600
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000005
- to stream Pmc, to step Curation: 000005
- to stream Pmc, to step Checkpoint: 000109
- to stream PubMed, to step Corpus: 000A56
- to stream PubMed, to step Curation: 000A56
- to stream PubMed, to step Checkpoint: 000959
- to stream Ncbi, to step Merge: 003A25
- to stream Ncbi, to step Curation: 003A25
- to stream Ncbi, to step Checkpoint: 003A25
- to stream Main, to step Merge: 000945
- to stream Main, to step Curation: 000945
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">L-DOPA treatment duration versus Parkinson's Disease
progression: The dorsal-ventral divide</title><author><name sortKey="Belujon, Pauline" sort="Belujon, Pauline" uniqKey="Belujon P" first="Pauline" last="Belujon">Pauline Belujon</name></author><author><name sortKey="Grace, Anthony A" sort="Grace, Anthony A" uniqKey="Grace A" first="Anthony A." last="Grace">Anthony A. Grace</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">23401218</idno><idno type="pmc">4460600</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460600</idno><idno type="RBID">PMC:4460600</idno><idno type="doi">10.1002/mds.25334</idno><date when="2013">2013</date><idno type="wicri:Area/Pmc/Corpus">000005</idno><idno type="wicri:Area/Pmc/Curation">000005</idno><idno type="wicri:Area/Pmc/Checkpoint">000109</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">000A56</idno><idno type="wicri:Area/PubMed/Curation">000A56</idno><idno type="wicri:Area/PubMed/Checkpoint">000959</idno><idno type="wicri:Area/Ncbi/Merge">003A25</idno><idno type="wicri:Area/Ncbi/Curation">003A25</idno><idno type="wicri:Area/Ncbi/Checkpoint">003A25</idno><idno type="wicri:doubleKey">0885-3185:2013:Belujon P:l:dopa:treatment</idno><idno type="wicri:Area/Main/Merge">000945</idno><idno type="wicri:Area/Main/Curation">000945</idno><idno type="wicri:Area/Main/Exploration">000945</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">L-DOPA treatment duration versus Parkinson's Disease
progression: The dorsal-ventral divide</title><author><name sortKey="Belujon, Pauline" sort="Belujon, Pauline" uniqKey="Belujon P" first="Pauline" last="Belujon">Pauline Belujon</name></author><author><name sortKey="Grace, Anthony A" sort="Grace, Anthony A" uniqKey="Grace A" first="Anthony A." last="Grace">Anthony A. Grace</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><date when="2013">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (adverse effects)</term><term>Basal Ganglia (physiopathology)</term><term>Dopamine Agents (adverse effects)</term><term>Female</term><term>Humans</term><term>Male</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (physiopathology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term><term>Dopamine Agents</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Basal Ganglia</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Male</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list></list><tree><noCountry><name sortKey="Belujon, Pauline" sort="Belujon, Pauline" uniqKey="Belujon P" first="Pauline" last="Belujon">Pauline Belujon</name><name sortKey="Grace, Anthony A" sort="Grace, Anthony A" uniqKey="Grace A" first="Anthony A." last="Grace">Anthony A. Grace</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000945 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000945 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:4460600
|texte= L-DOPA treatment duration versus Parkinson's Disease
progression: The dorsal-ventral divide
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23401218" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |